SCHEMBL4073210

SCHEMBL4073210

CC(C)(C)[C@@](CO)(Cc1ccccc1)NC(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.46
ALDH1A1 P00352 2/20 0.46
CYP2C19 P33261 2/20 0.46
CYP2C9 P11712 1/20 0.46
RECQL P46063 2/20 0.44
CYP1A2 P05177 1/20 0.44
MMP8 P22894 4/20 0.43
MAPK1 P28482 1/20 0.43
LMNA P02545 2/20 0.42
CYP2D6 P10635 2/20 0.42
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
HIF1A Q16665 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MAPT P10636 1/20 0.41
SLC6A2 P23975 1/20 0.40
TAAR1 Q96RJ0 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
ALOX15 P16050 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1273081 1.00 CYP3A4 (0.46) CYP3A4ALDH1A1CYP2C19CYP2C9RECQL
SCHEMBL3725498 0.87 KDM4E (0.51) ALDH1A1NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL4594149 0.86 RAB9A (0.43) ALDH1A1MAPK1NPC1RAB9ASMN1; SMN2
SCHEMBL4773478 0.86 LMNA (0.41) CYP3A4ALDH1A1CYP2C19CYP2C9MMP8
SCHEMBL4583207 0.85 CYP3A4 (0.50) CYP3A4ALDH1A1CYP2C19CYP2C9RECQL
SCHEMBL4379160 0.84 FDPS (0.46) CYP3A4ALDH1A1CYP2C19CYP2C9RECQL
SCHEMBL1539491 0.84 VNN1 (0.42) RAB9ATAAR1MEN1KMT2ARIPK1
SCHEMBL3960044 0.84 RIPK1 (0.41) ALDH1A1NPC1RAB9ASMN1; SMN2TAAR1
SCHEMBL16757585 0.84 CYP2C9 (0.44) CYP3A4ALDH1A1CYP2C19CYP2C9RECQL
SCHEMBL4596217 0.84 NPC1 (0.45) CYP3A4ALDH1A1CYP2C19CYP2C9CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1653961-A4 INHIBITORS OF AKT ACTIVITY SMITHKLINE BEECHAM CORP (US) 2009-04-01 EP disclosed
EP-1874768-A2 INHIBITORS OF AKT ACTIVITY SMITHKLINE BEECHAM CORPORATION (US) 2008-01-09 EP disclosed
WO-2006113837-A2 INHIBITORS OF AKT ACTIVITY SMITHKLINE BEECHAM CORPORATION (US) 2006-10-26 WO disclosed
EP-1653961-A1 INHIBITORS OF AKT ACTIVITY SMITHKLINE BEECHAM CORPORATION (US) 2006-05-10 EP disclosed
WO-2005011700-A1 INHIBITORS OF Akt ACTIVITY SMITHKLINE BEECHAM CORPORATION (US) 2005-02-10 WO disclosed